ShengFengCaiMDPhD

PubMed

• In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.
  Robert L Bowman, Andrew J Dunbar, Tanmay Mishra, Wenbin Xiao, Michael R Waarts
  Cancer Cell. 2024-11-11
• A View of Myeloid Transformation through the Hallmarks of Cancer.
  Inés Fernández-Maestre, Sheng F Cai, Ross L Levine
  Blood Cancer Discovery. 2024-11-01
• 1 citations
  CRISPR Dependency Screens in Primary Hematopoietic Stem Cells Identify KDM3B as a Genotype-specific Vulnerability in IDH2- and TET2-mutant Cells.
  Michael R Waarts, Shoron Mowla, Meaghan Boileau, Anthony R Martinez Benitez, Junya Sango
  Cancer Discovery. 2024-10-04

Journal Articles

• Article HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis  
  Ross L Levine, Jay L Hess, Sheng Cai, Scott A Armstrong, ScienceDirect

Abstracts/Posters

• A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia
  Sheng F Cai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism
  Sheng F. Cai, MD, PhD, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018